​

Funding Round

Series B - R-Zero

Series B - R-Zero

Investment Firm

Overview

R-Zero is a biosafety technology company dedicated to making shared indoor environments safer, healthier, and more productive.

Announced Date

Jun 16, 2021

Funding Type

Series B

Highlights

Location

United States, North America

Social

Investor Lead

John Doerr

John Doerr

John Doerr is a seed firm.

WiL (World Innovation Lab)

WiL (World Innovation Lab)

WiL (World Innovation Lab) is a early_stage_venture and late_stage_venture and venture firm.

Mayo Clinic Ventures

Mayo Clinic Ventures

Mayo Clinic Ventures is a early_stage_venture and late_stage_venture and seed firm.

Participant Investors

5

Investor Name
Participant InvestorMayo Clinic Ventures
Participant InvestorWiL (World Innovation Lab)
Participant InvestorSOSV
Participant InvestorJohn Doerr
Participant InvestorDBL Partners

Round Details and Background

R-Zero raised $50000000 on 2021-06-16 in Series B

R-Zero is a biosafety technology company dedicated to making shared indoor environments safer, healthier, and more productive.

Company Funding History

6

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Jun 16, 2021
Series B - R-Zero
5-50.0M
Sep 30, 2020
Series A - R-Zero
5-15.0M
May 12, 2022
Series C - R-Zero
2-undefined
Feb 14, 2023
Series C - R-Zero
10-105.0M

Recent Activity

There is no recent news or activity for this profile.